Follow
Miriam Ragle Aure
Miriam Ragle Aure
Dept. of Medical Genetics, University of Oslo and Oslo University Hospital
Verified email at medisin.uio.no
Title
Cited by
Cited by
Year
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
S Nik-Zainal, H Davies, J Staaf, M Ramakrishna, D Glodzik, X Zou, ...
Nature 534 (7605), 47-54, 2016
21922016
Pan-cancer analysis of whole genomes
Nature 578 (7793), 82-93, 2020
1718*2020
miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors
E Enerly, I Steinfeld, K Kleivi, SK Leivonen, MR Aure, HG Russnes, ...
PloS one 6 (2), e16915, 2011
3432011
Breast cancer quantitative proteome and proteogenomic landscape
HJ Johansson, F Socciarelli, NM Vacanti, MH Haugen, Y Zhu, I Siavelis, ...
Nature communications 10 (1), 1600, 2019
1782019
Targeted exploration and analysis of large cross-platform human transcriptomic compendia
Q Zhu, AK Wong, A Krishnan, MR Aure, A Tadych, R Zhang, DC Corney, ...
Nature methods 12 (3), 211-214, 2015
1472015
Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors
A Tahiri, SK Leivonen, T Lüders, I Steinfeld, M Ragle Aure, J Geisler, ...
Carcinogenesis 35 (1), 76-85, 2014
1432014
Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c
MK Nygren, C Tekle, VA Ingebrigtsen, R Mäkelä, M Krohn, MR Aure, ...
British journal of cancer 110 (8), 2072-2080, 2014
1332014
Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors
MR Aure, SK Leivonen, T Fleischer, Q Zhu, J Overgaard, J Alsner, ...
Genome biology 14, 1-20, 2013
1102013
Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome
MR Aure, V Vitelli, S Jernström, S Kumar, M Krohn, EU Due, TH Haukaas, ...
Breast Cancer Research 19, 1-18, 2017
1022017
Molecular features of subtype-specific progression from ductal carcinoma in situ to invasive breast cancer
R Lesurf, MR Aure, HH Mørk, V Vitelli, T Sauer, J Geisler, S Hofvind, ...
Cell reports 16 (4), 1166-1179, 2016
1002016
Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteins
S Myhre, OC Lingjærde, BT Hennessy, MR Aure, MS Carey, J Alsner, ...
Molecular oncology 7 (3), 704-718, 2013
852013
LIMT is a novel metastasis inhibiting lnc RNA suppressed by EGF and downregulated in aggressive breast cancer
A Sas‐Chen, MR Aure, L Leibovich, S Carvalho, Y Enuka, C Körner, ...
EMBO molecular medicine 8 (9), 1052-1064, 2016
832016
Metabolic clusters of breast cancer in relation to gene-and protein expression subtypes
TH Haukaas, LR Euceda, GF Giskeødegård, S Lamichhane, M Krohn, ...
Cancer & metabolism 4, 1-14, 2016
732016
miRNA551b-3p activates an oncostatin signaling module for the progression of triple-negative breast cancer
D Parashar, A Geethadevi, MR Aure, J Mishra, J George, C Chen, ...
Cell reports 29 (13), 4389-4406. e10, 2019
702019
Identifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression data
MR Aure, I Steinfeld, LO Baumbusch, K Liestøl, D Lipson, S Nyberg, ...
PloS one 8 (1), e53014, 2013
692013
Subtype‐specific micro‐RNA expression signatures in breast cancer progression
VD Haakensen, V Nygaard, L Greger, MR Aure, B Fromm, IRK Bukholm, ...
International journal of cancer 139 (5), 1117-1128, 2016
682016
Copy number gain of hsa-miR-569 at 3q26. 2 leads to loss of TP53INP1 and aggressiveness of epithelial cancers
P Chaluvally-Raghavan, F Zhang, S Pradeep, MP Hamilton, X Zhao, ...
Cancer Cell 26 (6), 863-879, 2014
532014
Integrated analysis reveals microRNA networks coordinately expressed with key proteins in breast cancer
MR Aure, S Jernström, M Krohn, HKM Vollan, EU Due, E Rødland, ...
Genome medicine 7, 1-17, 2015
462015
miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer
EM Lindholm, M Ragle Aure, MH Haugen, K Kleivi Sahlberg, ...
Molecular oncology 13 (10), 2278-2296, 2019
392019
Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer
MR Aure, T Fleischer, S Bjørklund, J Ankill, JA Castro-Mondragon, ...
Genome medicine 13 (1), 72, 2021
342021
The system can't perform the operation now. Try again later.
Articles 1–20